Jonathan Fox
President bei EIDOS THERAPEUTICS, INC.
Vermögen: 198 032 $ am 31.03.2024
Profil
Jonathan C. Fox bekleidet die Position des President & Chief Medical Officer bei Eidos Therapeutics, Inc. In seiner früheren Laufbahn war er Chief Medical Officer bei MyoKardia, Inc, Senior Director-Clinical Cardiovascular Research bei Merck & Co, Inc, Vice President-Clinical Development bei AstraZeneca LP, Director-Clinical Pharmacology bei GlaxoSmithKline LLC, klinischer Professor an der University of Pennsylvania, Berater an der University of California, San Francisco und beratender Professor an der Stanford University. Jonathan C. Fox erhielt einen Doktortitel und einen Bachelor-Abschluss von der University of Chicago.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
26.12.2023 | 10 857 ( 0,01% ) | 198 032 $ | 31.03.2024 |
Aktive Positionen von Jonathan Fox
Unternehmen | Position | Beginn |
---|---|---|
EIDOS THERAPEUTICS, INC. | President | 01.10.2016 |
EDGEWISE THERAPEUTICS, INC. | Director/Board Member | 02.03.2023 |
BRIDGEBIO PHARMA, INC. | President | - |
ML Bio Solutions, Inc. | Director/Board Member | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jonathan Fox
Unternehmen | Position | Ende |
---|---|---|
MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | 30.09.2016 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 01.01.2012 |
Stanford University | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Jonathan Fox
The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
ML Bio Solutions, Inc. |